Horwitz EM - Search Results

1

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.

Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. Eastham JA, et al. Among authors: horwitz em. J Urol. 2022 Jul;208(1):10-18. doi: 10.1097/JU.0000000000002757. Epub 2022 May 10. J Urol. 2022. PMID: 35536144

2

Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels.

Vicini FA, Horwitz EM, Gonzalez J, Martinez AA. Vicini FA, et al. Among authors: horwitz em. J Urol. 1997 Aug;158(2):319-25. J Urol. 1997. PMID: 9224296 Review.

3

Hypoxic regions exist in human prostate carcinoma.

Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Movsas B, et al. Among authors: horwitz em. Urology. 1999 Jan;53(1):11-8. doi: 10.1016/s0090-4295(98)00500-7. Urology. 1999. PMID: 9886581

4

Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.

Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Greenberg RE, Stobbe C, Hanks GE, Pollack A. Movsas B, et al. Among authors: horwitz em. Urology. 2002 Oct;60(4):634-9. doi: 10.1016/s0090-4295(02)01858-7. Urology. 2002. PMID: 12385924

5

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Uzzo RG, et al. Among authors: horwitz em. Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4. Urology. 2003. PMID: 12670560

6

Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone.

Horwitz EM, Uzzo RG, Hanlon AL, Greenberg RE, Hanks GE, Pollack A. Horwitz EM, et al. J Urol. 2003 Jun;169(6):2153-7; discussion 2157-9. doi: 10.1097/01.ju.0000067181.52741.09. J Urol. 2003. PMID: 12771738

7

Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.

Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF. Diefenbach MA, et al. J Urol. 2003 Jul;170(1):166-9. doi: 10.1097/01.ju.0000070963.12496.cc. J Urol. 2003. PMID: 12796672

8

Positive prostate biopsy laterality and implications for staging.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Buyyounouski MK, et al. Among authors: horwitz em. Urology. 2003 Aug;62(2):298-303. doi: 10.1016/s0090-4295(03)00334-0. Urology. 2003. PMID: 12893339

9

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA. Pollack A, et al. Among authors: horwitz em. World J Urol. 2003 Sep;21(4):200-8. doi: 10.1007/s00345-003-0356-x. Epub 2003 Sep 5. World J Urol. 2003. PMID: 12961097 Review.

10

Prostate cancer radiotherapy dose response: an update of the fox chase experience.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE. Pollack A, et al. Among authors: horwitz em. J Urol. 2004 Mar;171(3):1132-6. doi: 10.1097/01.ju.0000111844.95024.74. J Urol. 2004. PMID: 14767286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters